James C Shaw

Summary

Affiliation: University of Toronto
Country: Canada

Publications

  1. ncbi Hormonal therapies in acne
    James C Shaw
    Division of Dermatology, Toronto Western Hospital, East Wing 8 517, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada
    Expert Opin Pharmacother 3:865-74. 2002
  2. ncbi Long-term safety of spironolactone in acne: results of an 8-year followup study
    James C Shaw
    Division of Dermatology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada
    J Cutan Med Surg 6:541-5. 2002
  3. ncbi Acne: effect of hormones on pathogenesis and management
    James C Shaw
    Division of Dermatology, University of Toronto, Toronto Western Hospital, 355 Bathurst Street EW 8 517, Toronto, M5T 258 Ontario, Canada
    Am J Clin Dermatol 3:571-8. 2002
  4. ncbi Dermatology in the time of SARS
    James C Shaw
    University of Toronto, Toronto, Ontario, Canada
    Arch Dermatol 139:853-4. 2003
  5. ncbi Socioeconomic status influences care of patients with acne in Ontario, Canada
    Aamir Haider
    Division of Dermatology, University of Toronto, Toronto, Ontario, Canada
    J Am Acad Dermatol 54:331-5. 2006
  6. ncbi Treatment of acne vulgaris
    Aamir Haider
    Division of Dermatology, University of Toronto, Toronto, Ontario
    JAMA 292:726-35. 2004
  7. ncbi An American dermatologist goes to Canada: lessons from a single-payer healthcare system
    James C Shaw
    Division of Dermatology, University of Toronto, Ontario
    J Am Acad Dermatol 51:973-6. 2004
  8. ncbi Acne, antibiotics, and upper respiratory tract infections
    An-Wen Chan
    Arch Dermatol 141:1157-8. 2005
  9. ncbi Specialty clinics for the dermatologic care of solid-organ transplant recipients
    Leslie J Christenson
    Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Dermatol Surg 30:598-603. 2004
  10. ncbi A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris
    James Leyden
    University of Pennsylvania Hospital, 36th and Spruce Streets, Philadelphia, PA 19104, USA
    J Am Acad Dermatol 50:443-7. 2004

Collaborators

Detail Information

Publications11

  1. ncbi Hormonal therapies in acne
    James C Shaw
    Division of Dermatology, Toronto Western Hospital, East Wing 8 517, 399 Bathurst Street, Toronto, Ontario, M5T 2S8, Canada
    Expert Opin Pharmacother 3:865-74. 2002
    ..The main treatments to be discussed are oral contraceptives androgen receptor blockers like spironolactone and flutamide, inhibitors of the enzyme 5 alpha-reductase and topical hormonal treatments...
  2. ncbi Long-term safety of spironolactone in acne: results of an 8-year followup study
    James C Shaw
    Division of Dermatology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada
    J Cutan Med Surg 6:541-5. 2002
    ..No long-term studies of the safety of spironolactone used in this manner have been published. We present a study of the long-term safety and tolerance of spironolactone in 91 women with acne who were followed for up to 8 years...
  3. ncbi Acne: effect of hormones on pathogenesis and management
    James C Shaw
    Division of Dermatology, University of Toronto, Toronto Western Hospital, 355 Bathurst Street EW 8 517, Toronto, M5T 258 Ontario, Canada
    Am J Clin Dermatol 3:571-8. 2002
    ....
  4. ncbi Dermatology in the time of SARS
    James C Shaw
    University of Toronto, Toronto, Ontario, Canada
    Arch Dermatol 139:853-4. 2003
  5. ncbi Socioeconomic status influences care of patients with acne in Ontario, Canada
    Aamir Haider
    Division of Dermatology, University of Toronto, Toronto, Ontario, Canada
    J Am Acad Dermatol 54:331-5. 2006
    ..CONCLUSION: Within Canada's universal health care system, those likely to be in lower socioeconomic groups are significantly less likely to visit a dermatologist for specialist consultation...
  6. ncbi Treatment of acne vulgaris
    Aamir Haider
    Division of Dermatology, University of Toronto, Toronto, Ontario
    JAMA 292:726-35. 2004
    ..CONCLUSIONS: Acne responses to treatment vary considerably. Frequently more than 1 treatment modality is used concomitantly. Best results are seen when treatments are individualized on the basis of clinical presentation...
  7. ncbi An American dermatologist goes to Canada: lessons from a single-payer healthcare system
    James C Shaw
    Division of Dermatology, University of Toronto, Ontario
    J Am Acad Dermatol 51:973-6. 2004
  8. ncbi Acne, antibiotics, and upper respiratory tract infections
    An-Wen Chan
    Arch Dermatol 141:1157-8. 2005
  9. ncbi Specialty clinics for the dermatologic care of solid-organ transplant recipients
    Leslie J Christenson
    Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Dermatol Surg 30:598-603. 2004
    ..Regardless of the clinic design used, an organized and firmly established clinic model to allow proactive and ongoing care for these patients is important for education, prevention, and early intervention...
  10. ncbi A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris
    James Leyden
    University of Pennsylvania Hospital, 36th and Spruce Streets, Philadelphia, PA 19104, USA
    J Am Acad Dermatol 50:443-7. 2004
    ..These results indicate the need for further work at the molecular level to better understand the action of androgens on sebaceous gland function...
  11. ncbi Compliance with sun protection following organ transplantation
    Jeffrey C H Donovan
    Arch Dermatol 142:1232-3. 2006